Track-and-trace law pushing changes in Brazil

By Bob Moser
Correspondent

Published: June 9, 2014 2:41 pm ET
Updated: June 9, 2014 2:46 pm ET

David Dejean, a vice president at Systech International, said Brazil is a step ahead when it comes to tracking and tracy pharmaceuticals.

Related to this story

Topics Public Policy South America Medical/Pharmaceutical
Companies & Associations

SÃO PAULO — Serialization, one of the most important issues facing the global pharmaceutical industry today, has been placed front and center in Brazil after federal regulator ANVISA instituted a new law last year for track-and-trace aggregation by companies throughout the pharmaceutical supply chain, with deadlines for implementation looming in 2016.

Reports of seized counterfeit medicines have grown an average of 26 percent per year worldwide over the past decade, with the World Health Organization estimating that counterfeit medicine is a $75 billion per year industry. The biggest concern driving countries toward traceability laws isn’t the revenue loss in pharmaceuticals, but the bioterrorism risk of rogue ingredients killing patients with no traceability, said David Dejean, vice president at Systech International, a company specializing in authentication technologies.

Track-and-trace systems using alphanumeric barcodes allow data to be collected from each step in the supply chain, improving security, taxation and health care reimbursement. It can also provide a new level of transparency for patients, who can learn the history of their specific medicine by scanning a package’s QR code with their smartphone.

“There’s so much untapped potential in the value side of this movement, that it becomes a much different conversation within the organization about how I can gain value by using it to build trust with clients,” said Dejean, who spoke on the topic at Plastics News’ Brazil Pharma Summit, held in conjunction with Brazilian trade show FCE Pharma-Cosmetique, May 12-14.

Brazilian producers face challenges in integrating track and trace tools into their systems between now and the deadline in late 2016, but countries like Turkey, China and South Korea, among others, offer models of success for integrating traceability laws into their pharma industries, and Brazil is already moving faster toward the goal than the United States.

“Brazil is among the most hot-moving markets for this area, and it’s already seven years ahead of the U.S. for track-and-trace implementation,” said Dejean, citing a 2023 deadline for the U.S. pharma sector to institute similar standards. “What Brazil did well was it came out with an original law in 2009, but that was very intrusive to manufacturers, and the government listened to the industry about those flaws.”

Regulator ANVISA rescinded the 2009 law, visited with countries like Turkey to learn more, and set a foundation for the new 2013 law that’s based on industry feedback, Dejean added. But Brazil’s government did demand some specific things in the new serialization law that may be overbearing, like requiring a unique 13-digit serial number for each unit of each product a manufacturer produces.

One of the biggest outstanding questions for Brazil is how and when imported pharmaceuticals will be marked with the national standard tracking numbers. Brazilian pharma trade associations are asking ANVISA for clarity on unresolved issues like this to ensure rules are uniform for all medicine in the country, but the clock is now ticking toward 2016.

“ANVISA should have just required a data matrix code, but they went beyond their expertise and got too specific,” Dejean said. “That’s where GS1 standards should be brought in to make this process much easier.”

Ana Paula Maneiro

Argentina and India are among dozens of countries using supply chain standards from recognized global non-profit GS1 for their pharmaceutical sector traceability laws. Brazil should do the same to streamline the process, using open technology that’s proven to help pharma companies save millions annually in loss prevention and efficiency gains, said Ana Paula Maneiro, director of GS1 Brasil.

If Brazilian producers wait for every question to be solved by ANVISA, the 2016 deadline will come and go with little effect, said Eduardo Salles, commercial director with Dotter do Brasil, which offers a software solution for pharma companies to adapt to serialization.

“Six months have passed since the ANVISA regulation started [in December], and few companies have gotten things rolling,” Salles said. “Many suppliers in Brazil talk only of problems and fears, but this attitude only delays the tough decisions. We say enough is enough, you can implement a software solution quite easily over six months using your existing hardware.”

Brazilian producers need to get started now on getting the heavy track-and-trace investment done in their production lines, said Systech’s Dejean.

“Then they can fine-tune their methods as the law is refined,” Dejean said.


Comments

Track-and-trace law pushing changes in Brazil

By Bob Moser
Correspondent

Published: June 9, 2014 2:41 pm ET
Updated: June 9, 2014 2:46 pm ET

Post Your Comments


Back to story


More stories

Image

Commerce Department agrees to investigate PET dumping complaint

April 1, 2015 1:42 pm ET

UPDATED — A flood of alleged low-priced PET resin imports has led three U.S. PET makers to seek anti-dumping duties.    More

Image

Amut exec calls for a new approach to improve recycling

April 1, 2015 1:14 pm ET

Things have to change in order for recycling rates to increase and contamination to decrease, said the president of Amut North America during NPE...    More

Image

Polymer Additives, Lubrizol expansions win tax incentives

March 31, 2015 10:22 am ET

Proposed expansions by Polymer Additives Inc. in Cuyahoga County, Ohio, and Lubrizol Corp. in Lake County, Ohio, were among 12 projects statewide...    More

Image

Nanotechnology isn't science fantasy

March 30, 2015 12:15 pm ET

ORLANDO, FLA. — Nanotechnology is fast moving from the world of science fiction to science fact, with developments and...    More

Image

Mucell adds polypropylene parts to its potential resin applications

March 30, 2015 11:59 am ET

Structural polypropylene applications are now candidates for the use of Mucell microcellular foaming technology.    More

Market Reports

Trends in Resin Distribution

The growth of the North American resin distribution market is undeniable - and industry analysts are confident that growth will continue in 2015 and beyond.

This new report analyzes market trends and provides data on historical sales trends for PE (distribution and resellers), PolyOne Distribution figures, U.S. ethylene expansions based on shale gas and natural gas production by category to 2035.

Learn more

Plastics Recycling Trends in North America

This report is a review and analysis of the North American Plastics Recycling Industry, including key trends and statistics based on 2013 performance. We examine market environment factors, regulatory issues, industry challenges, key drivers and emerging trends in post-consumer and post-industrial recycling.

Learn more

Plastics in Mexico - State of the Industry Report

This report analyzes the $20 billion plastics industry in Mexico including sales of machinery & equipment, resins and finished products.

Our analysts provide insight on business trends, foreign investment, top end markets and plastics processing activity. The report also provides important data on exports, production, employment and value of plastics products manufactured.

Learn more

Upcoming Plastics News Events

June 2, 2015 - June 3, 2015Plastics Financial Summit - Chicago 2015

September 16, 2015 - September 18, 2015Plastics Caps & Closures - September 2015

More Events